1Q23

1Q23

• 1Q23 Earnings Release

  • Largest veterinary pharmaceutical laboratory of Brazilian origin and 3rd largest in the general ranking of SINDAN
  • Certified for the 3rd consecutive year as one of the best companies to work for by GPTW
  • Leverage reduction to 0.9x EBITDA, with 78% of long-term debt, 76% of all gross debt via FINEP and BNDES and average annual cost of 10.3%
  • Robust operating cash generation of R$91 million, R$74 million more than the same period of the previous year